News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
David Planchard: We Need to Work Together to Develop The Wave of New Treatments That Is Coming For Our Patients
David Planchard/oncostream.com
Jun 19, 2025, 16:57

David Planchard: We Need to Work Together to Develop The Wave of New Treatments That Is Coming For Our Patients

David Planchard, Thoracic Oncologist, Professor at the University Paris Saclay and Head of the Thoracic Cancer Group at the Gustave Roussy, shared a post on LinkedIn:

“Thanks organizing these joint meeting with different industries, scientists and medical oncologists like me to talk about Antibody Conjugates.
We need to work together to develop wave of new treatments that are coming for our patients (but still too little market access).”

David Planchard: We Need to Work Together to Develop The Wave of New Treatments That Is Coming For Our Patients

More posts featuring Antibody Conjugates.

Antibody Conjuguates cancer cancer treatment David Planchard OncoDaily Oncology
Special Coverage
Blog
Jul 27, 2025, 17:40
Aladina Foundation's Psychooncologists Offer a Consultation Outside the Hospital for Free
Opinion
Jul 27, 2025, 17:27
Ian Davis: Why Chemotherapy Has Not Stopped Working in Metastatic Prostate Cancer for More than 20 Years
Blog
Jul 27, 2025, 16:53
Luis E. Raez: The FLASCO “Breaking Barriers” Conference Returns This November
Career
Jul 27, 2025, 16:20
Justin Perry Has Been Promoted to Associate Member at Memorial Sloan Kettering Cancer Center
Blog
Jul 27, 2025, 16:04
Helena Linardou: ESMO Virtual Journal Club – July 2025 Edition
Blog
Jul 27, 2025, 15:57
A Deep Dive Into the Most Important Lung Cancer Trials Presented at ASCO25 - IASLC
Blog
Jul 27, 2025, 15:38
Sergio Cifuentes Canaval: First Meeting of Young Oncologists Group
Science
Jul 27, 2025, 15:14
Talha Badar: PII Trial of CPX-351 and Venetoclax
Insight
Jul 27, 2025, 15:13
Potential Breakthrough for Glioma: Servier’s Therapy Nears EMA Approval - Servier Pharmaceuticals
Blog
Jul 27, 2025, 15:03
Neil Gross: Giving an Update on the Progress of HN014 C-PRE for Skin CSCC Cancer
Blog
Jul 27, 2025, 14:26
Chadi Nabhan: How to Survive and Thrive in Fellowship?
Blog
Jul 27, 2025, 14:15
Alireza Mansouri: What Does the Clinical Community vs General Public Think of GBM Clinical Trials?